We reviewed our experience of 18F-FDG PET/CT in noncentral nervous system (CNS)
pediatric malignancies and evaluated if PET/CT provided additional information to …

The introduction of combined PET/CT into clinical practice has been greeted with much
enthusiasm among nuclear medicine physicians, radiologists and oncologists. Since the first …

Purpose To explore the impact of a true half dose of [18F]-FDG on image quality in pediatric
oncological patients undergoing total-body PET/CT and investigate short acquisition times …

Abstract Purpose 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET)
imaging has been used in the assessment of paediatric malignancies. PET/CT increases the …

Objective The objective of this retrospective study was to compare the diagnostic value of 2-
[18 F] fluoro-2-deoxy-d-glucose positron emission tomography (18 F-FDG PET)/CT versus …

Purpose Limited information is available on the use of positron emission tomography (PET)
in paediatric oncology. The aim of this study was to review the impact of PET on the …

Objective The purpose of these guidelines is to offer to the nuclear medicine team a
framework that could prove helpful in daily practice. These guidelines contain information …

In adults, 18F-FDG PET and PET/CT have proved to be useful tools in oncological patients
[1]. For example, it has been reported that PET can modify the initial staging in about 40% of …

The introduction of combined CT with the functional imaging modality of PET has been an
advancement in diagnostic imaging that has been welcomed by radiologists, nuclear …

Abstract Purpose In children with Hodgkin's disease and non-Hodgkin's lymphoma, the
ability of 18 F-fluoro-2-deoxy-D-glucose PET/CT and conventional imaging (CI) to detect …